bendamustine hydrochloride has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inayat, F; Law, JK; Myers-Gurevitch, PM; Perlman, AS; Seshan, SV | 1 |
| Caca, K; Kreth, F; Mössner, J; Preiss, R; Schoppmeyer, K; Wiedmann, M | 1 |
1 trial(s) available for bendamustine hydrochloride and Adenocarcinoma
| Article | Year |
|---|---|
A pilot study of bendamustine in advanced bile duct cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Bendamustine Hydrochloride; Bile Duct Neoplasms; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Liver Function Tests; Male; Metabolic Detoxication, Phase II; Middle Aged; Neoplasm Staging; Nitrogen Mustard Compounds; Pilot Projects | 2007 |
1 other study(ies) available for bendamustine hydrochloride and Adenocarcinoma
| Article | Year |
|---|---|
Minimal change disease: an unusual presentation of marginal zone MALT lymphoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Colonic Neoplasms; Diagnosis, Differential; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Nephrosis, Lipoid; Proteinuria; Rituximab | 2016 |